Skip to main content
. 2023 Apr 27;13(5):1093. doi: 10.3390/life13051093

Table 2.

DHX37 and NR5A1 variants identified in 46,XY PGD patients of this study.

Patient Gene Nucleotide/Amino Acid Alteration SNP ID Allele Frequency/Allele Count * In Silico Prediction Tools Inheritance
ACMG
Guidelines
CADD Score Mutation Taster PolyPhen SIFT
1 DHX37 c.923G>A/
p.Arg308Gln
rs1384892917 0.00006490 1/1 Pathogenic 33 Disease causing Probably damaging Deleterious Mother: WT
Father: NA
2 DHX37 c.1399C>G/
p.Leu467Val
rs149331610 0.0002952 1/38 VUS 22.2 Disease causing Probably damaging Deleterious Maternal
NR5A1 c.288_304del/
p.(Met98Glyfs*45)
NA NA - NA - - - Paternal
3 DHX37 c.2995G>A/
p.Val999Met
rs148710712 0.002316 2/54 Likely Benign 24.8 Disease causing Probably damaging Deleterious Paternal
NR5A1 c.11C>A/
p.(Ser4*)
NA NA - 37 - - - de novo
4 DHX37 c.2995G>A/
p.Val999Met
rs148710712 0.002316 2/54 Likely Benign 24.8 Disease causing Probably damaging Deleterious NA

NA: not available; SNP ID: single nucleotide polymorphism identification. VUS: variant of unknown significance; WT: wild type. * For this project, data from GnomAD (Genome Aggregation Database) database v2.1.1 were used based on the population with the highest allele frequency: 1 European (non-Finnish) population; 2 African/African American population.